Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease
Clinical trial NCT02927184 · COMPLETED
Trial details
- NCT number
- NCT02927184
- Sponsor
- Viking Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-28
- Primary completion
- 2019-03-26
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.